Top Pharmaceuticals, Biotechnology & Life Sciences Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
4.26 T
 0.14 
 1.22 
 0.17 
2NVO Novo Nordisk AS
290.4 B
(0.10)
 3.43 
(0.34)
3RDY Dr Reddys Laboratories
279.16 B
(0.11)
 1.55 
(0.17)
4JNJ Johnson Johnson
88.82 B
 0.17 
 1.18 
 0.20 
5MRK Merck Company
64.17 B
(0.07)
 1.77 
(0.12)
6PFE Pfizer Inc
63.63 B
 0.06 
 1.36 
 0.08 
7ABBV AbbVie Inc
56.33 B
 0.26 
 1.36 
 0.35 
8AZN AstraZeneca PLC ADR
54.07 B
 0.20 
 1.18 
 0.23 
9NVS Novartis AG ADR
51.72 B
 0.17 
 1.27 
 0.22 
10BMY Bristol Myers Squibb
48.3 B
 0.06 
 1.55 
 0.10 
11LLY Eli Lilly and
45.04 B
 0.08 
 1.92 
 0.15 
12SNY Sanofi ADR
44.29 B
 0.21 
 1.65 
 0.35 
13TMO Thermo Fisher Scientific
42.88 B
 0.00 
 1.54 
 0.00 
14AMGN Amgen Inc
33.42 B
 0.19 
 1.50 
 0.29 
15GSK GlaxoSmithKline PLC ADR
31.38 B
 0.12 
 1.76 
 0.21 
16GILD Gilead Sciences
28.75 B
 0.30 
 1.50 
 0.46 
17GMAB Genmab AS
21.53 B
 0.07 
 2.33 
 0.17 
18TEVA Teva Pharma Industries
16.54 B
(0.03)
 4.31 
(0.14)
19IQV IQVIA Holdings
15.4 B
(0.07)
 1.56 
(0.11)
20VTRS Viatris
14.74 B
(0.18)
 2.38 
(0.44)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.